Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
20 studies found for:    "Kawasaki disease"
Show Display Options
RSS Create an RSS feed from your search for:
"Kawasaki disease"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Etanercept in Kawasaki Disease
Conditions: Mucocutaneous Lymph Node Syndrome;   Kawasaki Disease
Interventions: Drug: Etanercept;   Drug: Placebo
2 Withdrawn Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease
Condition: Kawasaki Disease
Intervention: Drug: pravastatin
3 Recruiting Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial
Condition: Kawasaki Disease
Interventions: Drug: Infliximab;   Drug: IVIG
4 Unknown  Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease
Condition: Kawasaki Disease
Intervention: Other: Cardiac evaluation
5 Not yet recruiting Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease
Condition: Kawasaki Disease
Intervention: Drug: Anakinra
6 Completed
Has Results
Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease
Condition: Kawasaki Disease
Interventions: Drug: Infliximab;   Drug: Placebo
7 Recruiting Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki Disease
Conditions: Kawasaki Disease;   Aneurysm, Coronary
Intervention: Drug: Atorvastatin
8 Recruiting Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities
Condition: Kawasaki Disease
Intervention: Drug: Atorvastatin
9 Active, not recruiting Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease
Condition: Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin
Interventions: Drug: TA-650;   Drug: Polyethylene Glycol-treated Human Immunoglobulin (VGIH)
10 Recruiting Etiology Study of Kawasaki Disease
Condition: Kawasaki Disease
Intervention:
11 Completed
Has Results
Infliximab (Remicade) for Patients With Acute Kawasaki Disease
Condition: Kawasaki Disease
Interventions: Drug: Infliximab (Remicade);   Biological: Intravenous immunoglobulin (IVIG)
12 Completed Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease
Condition: Kawasaki Disease
Intervention: Drug: immunoglobulin G
13 Completed
Has Results
A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease
Condition: Kawasaki Disease
Intervention: Drug: Sestamibi
14 Not yet recruiting Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease
Conditions: Kawasaki Disease;   Coronary Aneurysm
Interventions: Drug: Doxycycline;   Drug: Standard care
15 Completed Prevention of Coronary Aneurysms in Kawasaki Syndrome
Conditions: Cardiovascular Diseases;   Coronary Aneurysm;   Heart Diseases;   Mucocutaneous Lymph Node Syndrome
Interventions: Drug: immunoglobulins, intravenous;   Drug: aspirin
16 Completed Reproductive Health in Men and Women With Vasculitis
Conditions: Giant Cell Arteritis;   Takayasu's Arteritis;   Polyarteritis Nodosa;   Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg-Strauss Syndrome;   Behcet's Disease;   Kawasaki Disease;   Henoch-schoenlein Purpura;   Vasculitis, Central Nervous System;   Drug-induced Necrotizing Vasculitis
Intervention:
17 Enrolling by invitation Real Time Myocardial Contrast Echocardiography and Dobutamine Stress Perfusion Magnetic Resonance Imaging
Conditions: Kawasaki Disease;   Heart Disease
Intervention:
18 Completed A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects
Condition: Kawasaki Disease
Intervention: Drug: Technetium Tc99m Sestamibi
19 Completed Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
Conditions: Primary Immunodeficiency Disorders;   Immune Thrombocytopenic Purpura (ITP);   Kawasaki Syndrome
Intervention: Procedure: Immune Globulin Intravenous (Human), 10%
20 Completed Trial of Pulse Steroid Therapy in Kawasaki Disease--Pediatric Heart Network
Conditions: Cardiovascular Diseases;   Heart Diseases;   Infection;   Coronary Aneurysm
Intervention: Drug: Steroids

Indicates status has not been verified in more than two years